Published in Int J Cardiovasc Imaging on February 20, 2011
QCA, IVUS and OCT in interventional cardiology in 2011. Cardiovasc Diagn Ther (2011) 0.88
Comparing Raman and fluorescence lifetime spectroscopy from human atherosclerotic lesions using a bimodal probe. J Biophotonics (2016) 0.77
Multicenter assessment of the reproducibility of volumetric radiofrequency-based intravascular ultrasound measurements in coronary lesions that were consecutively stented. Int J Cardiovasc Imaging (2012) 0.75
Compensatory enlargement of human atherosclerotic coronary arteries. N Engl J Med (1987) 9.79
Intracoronary stenting without anticoagulation accomplished with intravascular ultrasound guidance. Circulation (1995) 3.82
A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods. Lancet (2009) 3.55
Temporary scaffolding of coronary arteries with bioabsorbable magnesium stents: a prospective, non-randomised multicentre trial. Lancet (2007) 3.20
Coronary artery imaging with intravascular high-frequency ultrasound. Circulation (1990) 2.97
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation (2008) 2.62
Feasibility of combined use of intravascular ultrasound radiofrequency data analysis and optical coherence tomography for detecting thin-cap fibroatheroma. Eur Heart J (2008) 2.36
Intravascular ultrasound parameters associated with stent thrombosis after drug-eluting stent deployment. Am J Cardiol (2007) 2.32
Intravascular ultrasound-derived measures of coronary atherosclerotic plaque burden and clinical outcome. J Am Coll Cardiol (2010) 2.05
Intravascular ultrasound-guided optimized stent deployment. Immediate and 6 months clinical and angiographic results from the Multicenter Ultrasound Stenting in Coronaries Study (MUSIC Study) Eur Heart J (1998) 1.95
Atherosclerosis in angiographically "normal" coronary artery reference segments: an intravascular ultrasound study with clinical correlations. J Am Coll Cardiol (1995) 1.93
The dynamic nature of coronary artery lesion morphology assessed by serial virtual histology intravascular ultrasound tissue characterization. J Am Coll Cardiol (2010) 1.90
ECG-gated versus nongated three-dimensional intracoronary ultrasound analysis: implications for volumetric measurements. Cathet Cardiovasc Diagn (1998) 1.60
Impact of final stent dimensions on long-term results following sirolimus-eluting stent implantation: serial intravascular ultrasound analysis from the sirius trial. J Am Coll Cardiol (2004) 1.53
The potential clinical utility of intravascular ultrasound guidance in patients undergoing percutaneous coronary intervention with drug-eluting stents. Eur Heart J (2008) 1.45
Final results of the Can Routine Ultrasound Influence Stent Expansion (CRUISE) study. Circulation (2000) 1.39
ECG-gated three-dimensional intravascular ultrasound: feasibility and reproducibility of the automated analysis of coronary lumen and atherosclerotic plaque dimensions in humans. Circulation (1997) 1.26
Plaque distribution and vascular remodeling of ruptured and nonruptured coronary plaques in the same vessel: an intravascular ultrasound study in vivo. J Am Coll Cardiol (2001) 1.16
Safety and feasibility of frequency domain optical coherence tomography to guide decision making in percutaneous coronary intervention. EuroIntervention (2010) 1.15
IVUS-based imaging modalities for tissue characterization: similarities and differences. Int J Cardiovasc Imaging (2011) 1.15
Impact of plaque components on no-reflow phenomenon after stent deployment in patients with acute coronary syndrome: a virtual histology-intravascular ultrasound analysis. Eur Heart J (2009) 1.14
Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol (2008) 1.09
Assessment of normal and atherosclerotic arterial wall thickness with an intravascular ultrasound imaging catheter. Am Heart J (1990) 1.03
A randomized controlled trial of angiography versus intravascular ultrasound-directed bare-metal coronary stent placement (the AVID Trial). Circ Cardiovasc Interv (2009) 1.03
Detection and characterization of vascular lesions by intravascular ultrasound: an in vitro study correlated with histology. J Am Soc Echocardiogr (1992) 1.01
Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo. Int J Cardiovasc Imaging (2008) 1.01
Combined optical coherence tomography and intravascular ultrasound radio frequency data analysis for plaque characterization. Classification accuracy of human coronary plaques in vitro. Int J Cardiovasc Imaging (2010) 1.00
Are soft echoes really soft? Intravascular ultrasound assessment of mechanical properties in human atherosclerotic tissue. Am Heart J (1997) 0.98
Assessment of the absorption process following bioabsorbable everolimus-eluting stent implantation: temporal changes in strain values and tissue composition using intravascular ultrasound radiofrequency data analysis. A substudy of the ABSORB clinical trial. EuroIntervention (2009) 0.96
Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation (2004) 0.96
Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-to-moderate coronary atherosclerosis: an international multicentre study. EuroIntervention (2010) 0.93
Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. Circulation (2003) 0.92
Volumetric intracoronary ultrasound: a new maximum confidence approach for the quantitative assessment of progression-regression of atherosclerosis? Atherosclerosis (1995) 0.92
Assessment of coronary atherosclerosis by IVUS and IVUS-based imaging modalities: progression and regression studies, tissue composition and beyond. Int J Cardiovasc Imaging (2011) 0.87
Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis. J Am Coll Cardiol (2007) 0.87
Remodeling index compared to actual vascular remodeling in atherosclerotic left main coronary arteries as assessed with long-term (> or =12 months) serial intravascular ultrasound. J Am Coll Cardiol (2006) 0.86
Remodeling is a more important determinant of lumen size than atheroma burden in left main coronary artery disease. Am Heart J (2010) 0.82
Greyscale intravascular ultrasound and IVUS-radiofrequency tissue characterisation to improve understanding of the mechanisms of coronary stent thrombosis in drug-eluting stents. EuroIntervention (2008) 0.82
Assessment of drug-eluting stents and bioresorbable stents by grayscale IVUS and IVUS-based imaging modalities. Int J Cardiovasc Imaging (2011) 0.82
Analysis of backscattered ultrasound from normal and diseased arterial wall. Int J Card Imaging (1989) 0.81
Intravascular ultrasound imaging of arterial wall architecture. Echocardiography (1992) 0.80
Impact of analyzing less image frames per segment for radiofrequency-based volumetric intravascular ultrasound measurements in mild-to-moderate coronary atherosclerosis. Int J Cardiovasc Imaging (2010) 0.80
Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents. EuroIntervention (2010) 0.79
Is refined OCT guidance of stent implantation needed? EuroIntervention (2010) 0.77
Optimized expansion of the Wallstent compared with the Palmaz-Schatz stent: on-line observations with two- and three-dimensional intracoronary ultrasound after angiographic guidance. Am Heart J (1996) 0.77
Is there still a role for intravascular ultrasound in the current practice era? EuroIntervention (2010) 0.76
Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation (2008) 2.62
Aortoesophageal fistula secondary to stent-graft repair of the thoracic aorta. J Endovasc Ther (2004) 1.85
Value of plasma fibrin D-dimers for detection of acute aortic dissection. J Am Coll Cardiol (2004) 1.70
High dose adenosine for suboptimal myocardial reperfusion after primary PCI: A randomized placebo-controlled pilot study. Catheter Cardiovasc Interv (2008) 1.57
Systematic use of a collagen-based vascular closure device immediately after cardiac catheterization procedures in 1,317 consecutive patients. Catheter Cardiovasc Interv (2002) 1.55
Impact of gender on femoral access complications secondary to application of a collagen-based vascular closure device. J Invasive Cardiol (2004) 1.44
Dedicated calibration formulas permit correction of differences between measurements by different IVUS devices as demonstrated in atherosclerotic human coronary arteries in vitro. Int J Cardiovasc Imaging (2006) 1.43
Incidence of periprocedural myocardial infarction following stent implantation: comparison between first- and second-generation drug-eluting stents. Catheter Cardiovasc Interv (2011) 1.42
Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial. Catheter Cardiovasc Interv (2014) 1.40
Relation between baseline plaque burden and subsequent remodelling of atherosclerotic left main coronary arteries: a serial intravascular ultrasound study with long-term (> or =12 months) follow-up. Eur Heart J (2006) 1.39
Effect of a nurse-coordinated prevention programme on cardiovascular risk after an acute coronary syndrome: main results of the RESPONSE randomised trial. Heart (2013) 1.17
Impact of atherosclerotic plaque composition on coronary microembolization during percutaneous coronary interventions. Basic Res Cardiol (2008) 1.09
Delayed cardiac tamponade in a patient with previous minor blunt chest trauma. Int J Cardiol (2007) 1.09
Usefulness and safety of the GuideLiner catheter to enhance intubation and support of guide catheters: insights from the Twente GuideLiner registry. EuroIntervention (2012) 1.04
Reproducibility of volumetric intravascular ultrasound radiofrequency-based analysis of coronary plaque composition in vivo. Int J Cardiovasc Imaging (2008) 1.01
Preprocedural statin medication reduces the extent of periprocedural non-Q-wave myocardial infarction. Circulation (2002) 1.00
Relationship between cardiovascular risk as predicted by established risk scores versus plaque progression as measured by serial intravascular ultrasound in left main coronary arteries. Circulation (2004) 0.96
Advanced contour detection for three-dimensional intracoronary ultrasound: a validation--in vitro and in vivo. Int J Cardiovasc Imaging (2002) 0.95
Aspiration of embolized thrombus during primary percutaneous coronary intervention. Catheter Cardiovasc Interv (2009) 0.95
Between-centre reproducibility of volumetric intravascular ultrasound radiofrequency-based analyses in mild-to-moderate coronary atherosclerosis: an international multicentre study. EuroIntervention (2010) 0.93
Relation between progression and regression of atherosclerotic left main coronary artery disease and serum cholesterol levels as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound. Circulation (2003) 0.92
Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update. Eur J Echocardiogr (2011) 0.92
Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial. J Am Coll Cardiol (2013) 0.92
Percutaneous suture-mediated closure of femoral access sites deployed through the procedure sheath: initial clinical experience with a novel vascular closure device. Catheter Cardiovasc Interv (2003) 0.90
Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis. J Am Coll Cardiol (2007) 0.87
Two cases of pancreatic tuberculosis in nonimmunocompromised patients. A diagnostic challenge and a rare cause of portal hypertension. Pancreatology (2002) 0.87
Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries. J Am Coll Cardiol (2006) 0.87
Isolated "superdominant" single coronary artery: a particularly rare coronary anomaly. Heart (2007) 0.87
Remodeling index compared to actual vascular remodeling in atherosclerotic left main coronary arteries as assessed with long-term (> or =12 months) serial intravascular ultrasound. J Am Coll Cardiol (2006) 0.86
Staged therapeutic approach in spontaneous coronary dissection. Ann Thorac Surg (2007) 0.84
Activation of Ca2+ -activated potassium channels is involved in lysophosphatidylcholine-induced monocyte adhesion to endothelial cells. Atherosclerosis (2006) 0.84
Coating irregularities of durable polymer-based drug-eluting stents as assessed by scanning electron microscopy. EuroIntervention (2009) 0.83
Determinants of coronary blood flow in humans: quantification by intracoronary Doppler and ultrasound. J Appl Physiol (1985) (2004) 0.82
Scanning electron microscopic assessment of coating irregularities and their precursors in unexpanded durable polymer-based drug-eluting stents. Catheter Cardiovasc Interv (2012) 0.82
Comparison of frequency of periprocedural myocardial infarction in patients with and without diabetes mellitus to those with previously unknown but elevated glycated hemoglobin levels (from the TWENTE Trial). Am J Cardiol (2012) 0.81
Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design. EuroIntervention (2012) 0.81
Impact of analyzing less image frames per segment for radiofrequency-based volumetric intravascular ultrasound measurements in mild-to-moderate coronary atherosclerosis. Int J Cardiovasc Imaging (2010) 0.80
Is size really all that matters? Remarks on size and necrotic core content of atherosclerotic plaques. Int J Cardiovasc Imaging (2009) 0.80
Volumetric assessment of ulcerated ruptured coronary plaques with three-dimensional intravascular ultrasound in vivo. Am J Cardiol (2003) 0.80
Micro-computed tomographic assessment following extremely oversized partial postdilatation of drug-eluting stents. EuroIntervention (2010) 0.79
Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial. EuroIntervention (2015) 0.79
Severe regurgitation due to perforation of the mitral-aortic intervalvular fibrosa 3 years after aortic valve replacement. Eur J Echocardiogr (2011) 0.78
Is there a role for thoracic aortic calcium to fine-tune cardiovascular risk prediction? Int J Cardiovasc Imaging (2012) 0.78
Relation between plaque progression and low-density lipoprotein cholesterol during aging as assessed with serial long-term (> or =12 months) follow-up intravascular ultrasound of the left main coronary artery. Am J Cardiol (2006) 0.78
Polymer coatings on drug-eluting stents: Samson's hair and Achilles' heel? EuroIntervention (2013) 0.78
A novel four-dimensional angiographic approach to assess dynamic superficial wall stress of coronary arteries in vivo: Initial experience in evaluating vessel sites with subsequent plaque rupture. EuroIntervention (2017) 0.78
Endovascular stent-graft repair for penetrating atherosclerotic ulcer of the descending aorta. Am J Cardiol (2003) 0.77
Scanning electron microscopic assessment of the biodegradable coating on expanded biolimus-eluting stents. EuroIntervention (2009) 0.77
Evidence of myocardial scarring and microvascular obstruction on cardiac magnetic resonance imaging in a series of patients presenting with myocardial infarction without obstructed coronary arteries. Int J Cardiovasc Imaging (2014) 0.77
Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial. EuroIntervention (2015) 0.77
Assessment of the relation between initial culprit vessel patency in acute ST-elevation myocardial infarction and endothelial function. EuroIntervention (2014) 0.77
Cardiac imaging in a symptomatic patient with multiple coronary artery-left ventricular microfistulae. Heart Vessels (2007) 0.76
[Multiple rare causes of typical angina pectoris in a single patient]. Rev Esp Cardiol (2007) 0.76
Complex patients treated with zotarolimus-eluting resolute and everolimus-eluting Xience V stents in the randomized TWENTE trial: comparison of 2-year clinical outcome. Catheter Cardiovasc Interv (2014) 0.76
On the loss of the phosphorylcholine-based DES coating on the abluminal surface of Endeavor stents. Catheter Cardiovasc Interv (2010) 0.75
Artifactual measurement of low serum HDL-cholesterol due to paraproteinemia. Clin Res Cardiol (2010) 0.75
Beyond the lumen border: on the use of intravascular ultrasound in the left main coronary artery. EuroIntervention (2011) 0.75
The devil may be in the details...quantitative measurements in intravascular ultrasound images. Int J Cardiovasc Imaging (2004) 0.75
Coronary plaque burden and cardiovascular risk factors: single-point versus serial assessment. J Am Coll Cardiol (2006) 0.75
Fractional flow reserve measurements to identify justified targets for PCI in patients with stable angina: FAME 2 and beyond. Cardiovasc Diagn Ther (2012) 0.75
Multicenter assessment of the reproducibility of volumetric radiofrequency-based intravascular ultrasound measurements in coronary lesions that were consecutively stented. Int J Cardiovasc Imaging (2012) 0.75
Impact of analyzing fewer image frames per segment during offline volumetric radiofrequency-based intravascular ultrasound measurements of target lesions prior to percutaneous coronary interventions. Int J Cardiovasc Imaging (2011) 0.75
Novel ultrasonic insight into coronary arteries. Eur J Echocardiogr (2008) 0.75
Volumetric intravascular ultrasound measurements in coronary arteries. Int J Cardiovasc Imaging (2003) 0.75
Infarct tissue characterization in implantable cardioverter-defibrillator recipients for primary versus secondary prevention following myocardial infarction: a study with contrast-enhancement cardiovascular magnetic resonance imaging. Int J Cardiovasc Imaging (2012) 0.75
Reply: Post-Percutaneous Coronary Intervention Angina: A New Performance Measure? JACC Cardiovasc Interv (2015) 0.75
High-dose statins and atherosclerosis regression. JAMA (2006) 0.75
How should I treat multiple coronary aneurysms with severe stenoses? EuroIntervention (2015) 0.75
Impact of intraventricular conduction delay on coronary haemodynamics: a study with intracoronary Doppler in patients with bundle branch blocks and normal coronary arteries. Europace (2006) 0.75
Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial. EuroIntervention (2014) 0.75
Major dehiscence of infected aortic valve prosthesis with "rocking motion" but without diastolic paravalvular regurgitation. Int J Cardiovasc Imaging (2006) 0.75
Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents. EuroIntervention (2012) 0.75
First-in-man six-month results of a surface-modified coronary stent system in native coronary stenosis. EuroIntervention (2017) 0.75
Isolated "superdominant" single coronary artery: a particularly rare coronary anomaly. BMJ Case Rep (2009) 0.75
Three-year clinical outcome after treatment of chronic total occlusions with second-generation drug-eluting stents in the TWENTE trial. Catheter Cardiovasc Interv (2014) 0.75
DUrable polymer-based sTent CHallenge of Promus ElemEnt versus ReSolute integrity (DUTCH PEERS): rationale and study design of a randomized multicenter trial in a Dutch all-comers population. Am Heart J (2012) 0.75
Women treated with second-generation zotarolimus-eluting resolute stents and everolimus-eluting xience V stents: insights from the gender-stratified, randomized, controlled TWENTE trial. Catheter Cardiovasc Interv (2013) 0.75
Three-Year Clinical Outcome of Patients with Coronary Disease and Increased Event Risk Treated with Newer-Generation Drug-Eluting Stents: From the Randomized DUTCH PEERS Trial. Cardiology (2017) 0.75
Giant coronary aneurysm in Churg-Strauss syndrome. EuroIntervention (2012) 0.75
Clinical Outcomes After Percutaneous Coronary Intervention with the COMBO Stent versus Resolute Integrity and Promus Element Stents: A Propensity- Matched Analysis. EuroIntervention (2017) 0.75
How should I treat a patient with significant angina and a severe left anterior descending artery stenosis beyond the insertion of a left internal mammary artery jump graft (diagonal to LAD)? EuroIntervention (2012) 0.75
Functional comparison between BuMA Supreme biodegradable polymer sirolimus-eluting and durable polymer zotarolimus-eluting coronary stents using Quantitative Flow Ratio: PIONEER QFR substudy. EuroIntervention (2017) 0.75
Spectrum of remodeling behavior observed with serial long-term (>/=12 months) follow-up intravascular ultrasound studies in left main coronary arteries. Am J Cardiol (2004) 0.75